Masucci, Luca
 Distribuzione geografica
Continente #
EU - Europa 2.792
NA - Nord America 2.746
AS - Asia 1.676
SA - Sud America 421
AF - Africa 42
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.694
Nazione #
US - Stati Uniti d'America 2.678
SG - Singapore 690
IT - Italia 602
DE - Germania 537
SE - Svezia 513
CN - Cina 479
BR - Brasile 373
FR - Francia 240
PL - Polonia 240
IE - Irlanda 148
UA - Ucraina 103
GB - Regno Unito 98
IN - India 98
FI - Finlandia 86
ID - Indonesia 83
HK - Hong Kong 65
RU - Federazione Russa 53
AT - Austria 42
VN - Vietnam 42
CA - Canada 37
KR - Corea 37
TR - Turchia 35
BD - Bangladesh 26
BE - Belgio 26
NL - Olanda 26
CZ - Repubblica Ceca 17
ES - Italia 15
MX - Messico 15
AU - Australia 14
CH - Svizzera 12
IQ - Iraq 12
SA - Arabia Saudita 12
IR - Iran 11
JP - Giappone 11
LT - Lituania 11
MA - Marocco 11
VE - Venezuela 11
AR - Argentina 10
PH - Filippine 9
EC - Ecuador 7
TW - Taiwan 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
CO - Colombia 6
GR - Grecia 6
PK - Pakistan 6
CI - Costa d'Avorio 5
CY - Cipro 5
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
MY - Malesia 4
TN - Tunisia 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
NG - Nigeria 3
NO - Norvegia 3
PA - Panama 3
TH - Thailandia 3
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
OM - Oman 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 7.694
Città #
Chandler 441
Singapore 312
Warsaw 225
Ashburn 211
Dublin 146
Ann Arbor 116
Rome 114
Beijing 106
Fairfield 83
New York 82
Jacksonville 81
Jakarta 80
Milan 74
Wilmington 69
Woodbridge 69
San Mateo 61
Hong Kong 60
Munich 58
Boston 56
Chicago 56
Dearborn 54
Marseille 54
Los Angeles 52
Hefei 49
Nanjing 47
Princeton 43
Cattolica 41
Houston 40
Moscow 38
Seoul 37
Seattle 35
Helsinki 34
Frankfurt am Main 31
Redwood City 30
São Paulo 27
Izmir 25
Nuremberg 25
Pune 25
The Dalles 24
Boardman 23
Turku 23
London 22
Nürnberg 22
Lawrence 21
Brussels 20
Cambridge 20
Vienna 20
Zhengzhou 19
Hangzhou 18
Redmond 18
Falkenstein 17
San Francisco 17
Düsseldorf 16
Nanchang 16
Stockholm 15
Ho Chi Minh City 14
North Bergen 14
Paris 14
Augusta 13
Falls Church 13
Kunming 13
Hyderabad 12
Washington 12
Hebei 11
Melbourne 11
Mountain View 11
Norwalk 11
Rio de Janeiro 11
Shanghai 11
Shenyang 11
Tianjin 11
Toronto 11
Dhaka 10
Brooklyn 9
Florence 8
Lancaster 8
Ottawa 8
Santa Clara 8
Zurich 8
Baghdad 7
Belo Horizonte 7
Campinas 7
Guangzhou 7
Hanoi 7
Atlanta 6
Baku 6
Ceska 6
Council Bluffs 6
Detroit 6
Fremont 6
Kaohsiung 6
Lauterbourg 6
Mexico City 6
Roubaix 6
Abidjan 5
Amman 5
Amsterdam 5
Bari 5
Bologna 5
Bremen 5
Totale 3.906
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 423
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 223
The role of diet on gut microbiota composition 183
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 173
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 155
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 152
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 152
The effect of different antibiotic regimens on bacterial resistance: a systematic review 146
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 141
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 132
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 130
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 130
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 126
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 124
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 122
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 119
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 118
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 115
European consensus conference on faecal microbiota transplantation in clinical practice 112
Whole-genome sequencing reveals host factors underlying critical COVID-19 111
A patient with acute myeloid leukemia and a solid mass in the colon. 111
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 108
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 105
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 103
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 103
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 102
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 101
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 97
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 95
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 95
An explainable model of host genetic interactions linked to COVID-19 severity 93
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 93
Reply to Seligman 89
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 85
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 85
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 84
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 81
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 81
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 78
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 78
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 77
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 76
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 75
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 75
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 73
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 71
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 70
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 70
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 69
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 69
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 67
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 65
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 65
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 65
Laboratory handling practice for faecal microbiota transplantation 65
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 64
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 63
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 63
Fecal microbiota transplantation: What’s new? 62
Mapping the human genetic architecture of COVID-19 60
SARS-CoV-2 vaccines and donor recruitment for FMT 60
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 59
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 59
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 57
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 55
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 55
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 55
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 55
Laboratory handling practice for faecal microbiota transplantation 55
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 51
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 50
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 49
How the gut parasitome affects human health 49
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 49
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 47
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 47
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 44
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 44
Genetic mechanisms of critical illness in COVID-19 43
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 42
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 41
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 41
International consensus statement on microbiome testing in clinical practice 40
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 38
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 37
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 36
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 35
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 35
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 34
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 33
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 33
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 25
Clinical and molecular characterization of COVID-19 hospitalized patients 24
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 19
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 17
Totale 7.831
Categoria #
all - tutte 39.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 62 15 42 67 43 62 8 54 21 63 11
2021/2022611 69 27 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/20251.977 39 70 135 110 156 72 97 79 260 228 402 329
2025/2026771 710 61 0 0 0 0 0 0 0 0 0 0
Totale 7.831